Relias LLC |
Share:
|
Advances in™ Beta-Thalassemia: The Evolving Therapeutic Landscape
Target Audience
This educational activity is directed toward hematologists and hematologist-oncologists, as well as pediatricians, nurses, nurse practitioners, physician assistants, and other clinicians involved in the management of patients with beta-thalassemia.
Program Overview
This online educational activity is designed to provide expert interpretation of new and emerging data on the t...
|
|
Alpha-1 Antitrypsin Deficiency (AATD) Case Studies and Expert Perspectives: Screening, Diagnosis, and Augmentation Therapy
Target Audience
The intended audience for this activity is pulmonologists, allergists, hepatologists, gastroenterologists, respiratory therapists, and other health care providers who screen and manage patients with alpha-1 antitrypsin deficiency (AATD).
Program Overview
Alpha-1 antitrypsin deficiency (AATD) is one of the most prevalent genetic diseases. It is an uncommonly diagnosed, potent...
|
|
Beyond the Guidelines for CMV: Clinical Perspectives on Challenging Cases Post-Transplant: A Clinical Forum®
Target Audience
Infectious disease, transplantation, internal medicine, and nephrology clinicians
Program Overview
Cytomegalovirus (CMV) is a prevalent and potentially life-threatening viral infection in transplant recipients. CMV management in this high-risk population continues to evolve with updated guidelines and newer, less toxic antiviral therapy.
During this activity, faculty will...
|
|
Cognitive Impairment Associated With Schizophrenia: Evaluating Emerging Therapies
Target Audience
This educational activity has been designed to meet the needs of psychiatrists, psychiatry mental health therapists (eg, psychologists, social workers, case managers), nurse practitioners, physician assistants, pharmacists, primary care providers, and other clinicians involved in the management of patients with cognitive impairment associated with schizophrenia (CIAS).
Progra...
|
|
Evolving Treatment Paradigms in HR+/HER2- Early Breast Cancer: Advancing Equitable Care in Rural and Underserved Communities
Target Audience
This activity is designed specifically for oncologists, advanced practice providers, and other members of the healthcare team who serve patients from rural and underserved communities.
Program Overview
Hormone receptor"positive, human epidermal growth factor receptor 2"negative (HR+/HER2-) breast cancer accounts for up to 70% of all breast cancer cases. In recent y...
|
|
FcRn and Myasthenia Gravis
Target Audience
This activity has been designed to meet the educational needs of physicians specializing in neurology and ophthalmology who may be involved in the diagnosis and care of individuals with MG. Other healthcare providers, including neurology NPs and PAs, may also participate.
Program Overview
This 30-minute CME program discusses how the FcRn system can impact myasthenia gravis a...
|
|
Improving Equity in Endometrial Cancer Care and Treatment: Accelerating Change to Improve Patient Outcomes in Rural and Underserved Communities
Target Audience
This activity is designed specifically for oncologists, advanced practice providers, and other members of the healthcare team who serve patients from rural and underserved communities.
Program Overview
In rural and underserved communities, disparities in incidence, treatment, and prognosis are pervasive among women with endometrial cancer. Key factors contributing to these g...
|
|
In the Clinic: A Case-Based Discussion on Managing CSU
Target Audience
This activity has been designed to meet the educational needs of allergists, dermatologists, and primary care providers. It may also benefit nurse practitioners, PAs, and other clinicians who are interested in the management of patients with chronic spontaneous urticaria (CSU).
Program Overview
This engaging, sharply focused discussion between experts on CSU provides a case-...
|
|
Targeting the PI3K/AKT/PTEN Pathway for Treatment of Breast Cancer: Innovative Solutions for Equitable Care
Target Audience
This activity is designed specifically for oncologists, advanced practice providers, and other members of the healthcare team who serve patients from rural and underserved communities.
Program Overview
The PI3K/AKT/PTEN pathway has emerged as a key player in breast cancer development. Notably, up to 50% of patients with hormone receptor"positive, human epidermal growth ...
|
|